Niro expands pharmaceutical test center in Denmark

Copenhagen, Denmark-headquartered Niro is finalizing a 10.0 million-euro ($13.4 million) invest program centered on the expansion of its pharmaceutical testing site located at the firm's head office.

Already containing an extensive range of equipment for process and product evaluation, the modified facility will represent the largest of its kind in the world on completion, with over 35 different types of pilot plants available for client use, the group stated.

The new site, which operates under full Good Manufacturing Practice conditions and is approved by the Danish Medicines Agency for producing drugs for clinical trials, includes several pharmaceutical process lines to provide the widest range of spray-drying technology for product development, realistic testing and easy scale-up to maximum production size.